ENTRY       D11992                      Drug
NAME        Pavurutamab (USAN)
FORMULA     C4684H7154N1268O1466S38
EXACT_MASS  105837.3616
MOL_WEIGHT  105903.0076
SEQUENCE    QVQLVQSGAE VKKPGASVKV SCKASGYTFT NHIIHWVRQA PGQCLEWMGY INPYPGYHAY
            NEKFQGRATM TSDTSTSTVY MELSSLRSED TAVYYCARDG YYRDTDVLDY WGQGTLVTVS
            SGGGGSGGGG SGGGGSDIQM TQSPSSLSAS VGDRVTITCQ ASQDISNYLN WYQQKPGKAP
            KLLIYYTSRL HTGVPSRFSG SGSGTDFTFT ISSLEPEDIA TYYCQQGNTL PWTFGCGTKV
            EIKSGGGGSE VQLVESGGGL VQPGGSLKLS CAASGFTFNK YAMNWVRQAP GKGLEWVARI
            RSKYNNYATY YADSVKDRFT ISRDDSKNTA YLQMNNLKTE DTAVYYCVRH GNFGNSYISY
            WAYWGQGTLV TVSSGGGGSG GGGSGGGGSQ TVVTQEPSLT
            VSPGGTVTLT CGSSTGAVTS GNYPNWVQQK PGQAPRGLIG GTKFLAPGTP ARFSGSLLGG
            KAALTLSGVQ PEDEAEYYCV LWYSNRWVFG GGTKLTVLGG GGDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPCEEQYGS
            TYRCVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGKG GGGSGGGGSG GGGSGGGGSG GGGSGGGGSD
            KTHTCPPCPA PELLGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG
            VEVHNAKTKP CEEQYGSTYR CVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG
            QPREPQVYTL PPSREEMTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD
            GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Disulfide bridge: 22-96, 44-236, 159-224, 271-347, 411-479, 508-765, 511-768, 543-603, 574-584, 649-707, 800-860, 831-841, 906-964)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody, bispecific antibody
COMMENT     Treatment of multiple myeloma
TARGET      TNFRSF17 (BCMA, CD269) [HSA:608] [KO:K05153]
            CD3E [HSA:916] [KO:K06451]
  PATHWAY   hsa04060(608)  Cytokine-cytokine receptor interaction
            hsa04640(916)  Hematopoietic cell lineage
            hsa04660(916)  T cell receptor signaling pathway
            hsa04672(608)  Intestinal immune network for IgA production
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF17 (BCMA, CD269)
                 D11992  Pavurutamab (USAN)
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD3E
                 D11992  Pavurutamab (USAN)
DBLINKS     CAS: 2250292-39-6
///
